Immunohistochemistry Antibody Market Size, Share, Trends & Forecast
The Immunohistochemistry Antibody Market was valued at USD 2.4 billion in 2024 and USD 2.6 billion in 2025, with the market projected to reach USD 5 billion by 2035 at a 7.0% CAGR. Rising cancer incidence, increasing research activity, and growing demand for precision diagnostics are supporting market expansion.
Cancer diagnostics represents the leading application, valued at USD 1.3 billion in 2024 and projected to reach USD 2.5 billion by 2035. Infectious disease diagnosis, vaccine development, and research and development also contribute to demand for immunohistochemistry antibodies across clinical and research settings.
Primary antibodies are expected to hold the largest share among product types because of their central role in identifying specific antigens in tissue samples. Secondary antibodies, isotype controls, and biotinylated antibodies support signal detection, assay validation, and multiplex testing applications.
Technological advances are reshaping laboratory workflows through automated immunohistochemistry, digital pathology, and AI-supported analysis. Automated systems can improve consistency and throughput, while digital imaging facilitates data-driven pathology workflows and remote collaboration.